# 68Ga PSMA PET Imaging for the Treatment of Advanced Liver Cancer

> **NCT05176223** · PHASE2 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 29 (actual)

## Conditions studied

- Advanced Hepatocellular Carcinoma
- Stage III Hepatocellular Carcinoma AJCC v8
- Stage IV Hepatocellular Carcinoma AJCC v8
- Unresectable Hepatocellular Carcinoma

## Interventions

- **PROCEDURE:** Computed Tomography
- **DRUG:** Gallium Ga 68 Gozetotide
- **PROCEDURE:** Positron Emission Tomography

## Key facts

- **NCT ID:** NCT05176223
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-30
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2026-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05176223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05176223, "68Ga PSMA PET Imaging for the Treatment of Advanced Liver Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05176223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*